Singh, D., Vezzoli, S., Petruzzelli, S., & Papi, A. (2017). The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: A post hoc analysis of the FORWARD study. Int J Chron Obstruct Pulmon Dis.
Citación estilo ChicagoSingh, Dave, Stefano Vezzoli, Stefano Petruzzelli, y Alberto Papi. "The Efficacy of Extrafine Beclomethasone Dipropionate–formoterol Fumarate in COPD Patients Who Are Not “frequent Exacerbators”: A Post Hoc Analysis of the FORWARD Study." Int J Chron Obstruct Pulmon Dis 2017.
Cita MLASingh, Dave, Stefano Vezzoli, Stefano Petruzzelli, y Alberto Papi. "The Efficacy of Extrafine Beclomethasone Dipropionate–formoterol Fumarate in COPD Patients Who Are Not “frequent Exacerbators”: A Post Hoc Analysis of the FORWARD Study." Int J Chron Obstruct Pulmon Dis 2017.